Table 5.
Post hoc secondary analysis of the PPCPM vs usual care adjusted for baseline SBP, sex, and history of coronary artery disease
| Outcomes | PPCPM(n = 56) | Usual care(n = 56) | P value |
|---|---|---|---|
| SBP at 12‐mo follow‐up, mean (SD), mm Hg | 129.7 (13.79) | 146.1 (22.2) | <.0001 |
| DBP at 12‐mo follow‐up, mean (SD), mm Hg | 82.5 (9.41) | 88.9 (10.68) | .001 |
| Change in SBP from baseline, mean (SD), mm Hg | −27.7 (20.4) | −11.4 (23) | .0001 |
| Change in DBP from baseline, mean (SD), mm Hg | −19.16 (14.62) | −4.23 (12.5) | <.0001 |
| No. of days to goal BP, median (95% CI/IQR) | 30 (17–43/14–63) | 182 (98–290/91–365) | <.0001 |
| No. of visits during 12‐mo follow‐up period, mean (SD) | 6.44 (3.1) | 3.48 (1.8) | <.001 |
| No. of visits to goal BP, mean (SD) | 3.1 (1.2) | 2.8 (1.3) | .3324 |
| No. (%) at BP goal at 12‐mo follow‐up | 50 (89.2) | 23 (50) | <.0001 |
| Therapeutic inertiaa | 20.1 | 48.1 | <.0001 |
Categorical variables compared using chi‐square test; continuous variables compared using nonparametric Wilcoxon‐Mann‐Whitney test or time‐to‐event analysis–based log‐rank test.
Data sources: VCU Health System and Center for Healthy Hearts.
Abbreviations: BP, blood pressure; DBP, diastolic blood pressure; CI, confidence interval; IQR, interquartile range; PPCPM, pharmacist‐physician collaborative practice model; SBP, systolic blood pressure; SD, standard deviation.
a
Therapeutic inertia = (number of visits BP not at goal – number of visits with a medication change)/total number of visits.